#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Referent|entity|infstat
#T_RL=webanno.custom.Coref|type|BT_webanno.custom.Referent


#Text=1 .
1-1	0-1	1	quantity	new	_	_
1-2	2-3	.	_	_	_	_

#Text=Introduction
2-1	4-16	Introduction	abstract	new	_	_

#Text=Finding critical in vitro and/or in silico parameters ( descriptors or properties ) of the hit→lead→seed→drug route is still a long-term aspiration and monumental challenge in drug discovery projects , mainly due to the intrinsic multidimensionality of the problem .
3-1	17-24	Finding	_	_	_	_
3-2	25-33	critical	_	_	_	_
3-3	34-36	in	_	_	_	_
3-4	37-42	vitro	_	_	_	_
3-5	43-49	and/or	_	_	_	_
3-6	50-52	in	_	_	_	_
3-7	53-59	silico	event|abstract[4]	new|new[4]	coref|coref	16-30|16-30
3-8	60-70	parameters	abstract[4]	new[4]	_	_
3-9	71-72	(	_	_	_	_
3-10	73-84	descriptors	abstract	new	coref	14-24[125_0]
3-11	85-87	or	_	_	_	_
3-12	88-98	properties	abstract[6]	new[6]	coref	4-39[26_6]
3-13	99-100	)	abstract[6]	new[6]	_	_
3-14	101-103	of	abstract[6]	new[6]	_	_
3-15	104-107	the	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-16	108-126	hit→lead→seed→drug	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-17	127-132	route	abstract[6]|abstract[7]	new[6]|new[7]	_	_
3-18	133-135	is	_	_	_	_
3-19	136-141	still	abstract[8]	new[8]	_	_
3-20	142-143	a	abstract[8]	new[8]	_	_
3-21	144-153	long-term	abstract[8]	new[8]	_	_
3-22	154-164	aspiration	abstract[8]	new[8]	_	_
3-23	165-168	and	_	_	_	_
3-24	169-179	monumental	abstract[9]	new[9]	_	_
3-25	180-189	challenge	abstract[9]	new[9]	_	_
3-26	190-192	in	abstract[9]	new[9]	_	_
3-27	193-197	drug	abstract[9]|substance|abstract[12]	new[9]|new|new[12]	coref|coref|coref|coref	15-8|16-46[157_12]|15-8|16-46[157_12]
3-28	198-207	discovery	abstract[9]|abstract|abstract[12]	new[9]|new|new[12]	coref	16-47
3-29	208-216	projects	abstract[9]|abstract[12]	new[9]|new[12]	_	_
3-30	217-218	,	_	_	_	_
3-31	219-225	mainly	_	_	_	_
3-32	226-229	due	_	_	_	_
3-33	230-232	to	_	_	_	_
3-34	233-236	the	abstract[13]	new[13]	_	_
3-35	237-246	intrinsic	abstract[13]	new[13]	_	_
3-36	247-266	multidimensionality	abstract[13]	new[13]	_	_
3-37	267-269	of	abstract[13]	new[13]	_	_
3-38	270-273	the	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-39	274-281	problem	abstract[13]|abstract[14]	new[13]|new[14]	_	_
3-40	282-283	.	_	_	_	_

#Text=In concert with the medicinal chemist ’s intuition ( or serendipity ) , the computer-assisted molecular design ( CAMD ) approaches are regarded as an integral method for the exhaustive transformation of the compound topology or topography and/or the electronic properties into the property-based chemical space .
4-1	284-286	In	_	_	_	_
4-2	287-294	concert	event[15]	new[15]	_	_
4-3	295-299	with	event[15]	new[15]	_	_
4-4	300-303	the	event[15]|abstract[17]	new[15]|new[17]	_	_
4-5	304-313	medicinal	event[15]|person[16]|abstract[17]	new[15]|new[16]|new[17]	_	_
4-6	314-321	chemist	event[15]|person[16]|abstract[17]	new[15]|new[16]|new[17]	_	_
4-7	322-324	’s	event[15]|person[16]|abstract[17]	new[15]|new[16]|new[17]	_	_
4-8	325-334	intuition	event[15]|abstract[17]	new[15]|new[17]	_	_
4-9	335-336	(	event[15]	new[15]	_	_
4-10	337-339	or	event[15]	new[15]	_	_
4-11	340-351	serendipity	event[15]|abstract	new[15]|new	_	_
4-12	352-353	)	event[15]	new[15]	_	_
4-13	354-355	,	_	_	_	_
4-14	356-359	the	abstract[20]	new[20]	appos	4-19[0_20]
4-15	360-377	computer-assisted	abstract[20]	new[20]	_	_
4-16	378-387	molecular	abstract|abstract[20]	new|new[20]	_	_
4-17	388-394	design	abstract[20]	new[20]	_	_
4-18	395-396	(	_	_	_	_
4-19	397-401	CAMD	abstract	giv	_	_
4-20	402-403	)	_	_	_	_
4-21	404-414	approaches	abstract	new	_	_
4-22	415-418	are	_	_	_	_
4-23	419-427	regarded	_	_	_	_
4-24	428-430	as	_	_	_	_
4-25	431-433	an	_	_	_	_
4-26	434-442	integral	_	_	_	_
4-27	443-449	method	_	_	_	_
4-28	450-453	for	_	_	_	_
4-29	454-457	the	abstract[23]	new[23]	_	_
4-30	458-468	exhaustive	abstract[23]	new[23]	_	_
4-31	469-483	transformation	abstract[23]	new[23]	_	_
4-32	484-486	of	abstract[23]	new[23]	_	_
4-33	487-490	the	abstract[23]|abstract[24]	new[23]|new[24]	_	_
4-34	491-499	compound	abstract[23]|abstract[24]	new[23]|new[24]	_	_
4-35	500-508	topology	abstract[23]|abstract[24]	new[23]|new[24]	_	_
4-36	509-511	or	abstract[23]	new[23]	_	_
4-37	512-522	topography	abstract[23]|abstract[25]	new[23]|new[25]	_	_
4-38	523-529	and/or	abstract[23]|abstract[25]	new[23]|new[25]	_	_
4-39	530-533	the	abstract[23]|abstract[25]|abstract[26]	new[23]|new[25]|giv[26]	coref	15-9[134_26]
4-40	534-544	electronic	abstract[23]|abstract[25]|abstract[26]	new[23]|new[25]|giv[26]	_	_
4-41	545-555	properties	abstract[23]|abstract[25]|abstract[26]	new[23]|new[25]|giv[26]	_	_
4-42	556-560	into	abstract[23]|abstract[25]|abstract[26]	new[23]|new[25]|giv[26]	_	_
4-43	561-564	the	abstract[23]|abstract[25]|abstract[26]|abstract[27]	new[23]|new[25]|giv[26]|new[27]	_	_
4-44	565-579	property-based	abstract[23]|abstract[25]|abstract[26]|abstract[27]	new[23]|new[25]|giv[26]|new[27]	_	_
4-45	580-588	chemical	abstract[23]|abstract[25]|abstract[26]|abstract[27]	new[23]|new[25]|giv[26]|new[27]	_	_
4-46	589-594	space	abstract[23]|abstract[25]|abstract[26]|abstract[27]	new[23]|new[25]|giv[26]|new[27]	_	_
4-47	595-596	.	_	_	_	_

#Text=The systematic observational of trends of structural chemical modifications that produce corresponding changes in the biological responses for a congeneric series of molecules are fundamental for the multidimensional quantitative structure – activity ( mD-QSAR ) studies .
5-1	597-600	The	abstract[28]	new[28]	_	_
5-2	601-611	systematic	abstract[28]	new[28]	_	_
5-3	612-625	observational	abstract[28]	new[28]	_	_
5-4	626-628	of	abstract[28]	new[28]	_	_
5-5	629-635	trends	abstract[28]|abstract[29]	new[28]|new[29]	_	_
5-6	636-638	of	abstract[28]|abstract[29]	new[28]|new[29]	_	_
5-7	639-649	structural	abstract[28]|abstract[29]|abstract[30]	new[28]|new[29]|new[30]	coref	21-32[215_30]
5-8	650-658	chemical	abstract[28]|abstract[29]|abstract[30]	new[28]|new[29]|new[30]	_	_
5-9	659-672	modifications	abstract[28]|abstract[29]|abstract[30]	new[28]|new[29]|new[30]	_	_
5-10	673-677	that	_	_	_	_
5-11	678-685	produce	_	_	_	_
5-12	686-699	corresponding	_	_	_	_
5-13	700-707	changes	abstract[31]	new[31]	coref	8-21[65_31]
5-14	708-710	in	abstract[31]	new[31]	_	_
5-15	711-714	the	abstract[31]|abstract[32]	new[31]|new[32]	_	_
5-16	715-725	biological	abstract[31]|abstract[32]	new[31]|new[32]	_	_
5-17	726-735	responses	abstract[31]|abstract[32]	new[31]|new[32]	_	_
5-18	736-739	for	abstract[31]|abstract[32]	new[31]|new[32]	_	_
5-19	740-741	a	abstract[31]|abstract[32]|object[33]	new[31]|new[32]|new[33]	_	_
5-20	742-752	congeneric	abstract[31]|abstract[32]|object[33]	new[31]|new[32]|new[33]	_	_
5-21	753-759	series	abstract[31]|abstract[32]|object[33]	new[31]|new[32]|new[33]	_	_
5-22	760-762	of	abstract[31]|abstract[32]|object[33]	new[31]|new[32]|new[33]	_	_
5-23	763-772	molecules	abstract[31]|abstract[32]|object[33]|substance	new[31]|new[32]|new[33]|new	coref	9-12[70_0]
5-24	773-776	are	_	_	_	_
5-25	777-788	fundamental	_	_	_	_
5-26	789-792	for	_	_	_	_
5-27	793-796	the	abstract[35]	new[35]	appos	5-32[0_35]
5-28	797-813	multidimensional	abstract[35]	new[35]	_	_
5-29	814-826	quantitative	abstract[35]	new[35]	_	_
5-30	827-836	structure	abstract[35]	new[35]	_	_
5-31	837-838	–	_	_	_	_
5-32	839-847	activity	abstract	giv	appos	5-34
5-33	848-849	(	_	_	_	_
5-34	850-857	mD-QSAR	abstract	giv	appos	5-36
5-35	858-859	)	_	_	_	_
5-36	860-867	studies	abstract	giv	coref	7-19[54_0]
5-37	868-869	.	_	_	_	_

#Text=Moving from complex biological relationships to simple QSAR models seems to be a ‘ triumph of hope over experience , ’ since modelers sometimes are playing a ‘ glass bead game . ’
6-1	870-876	Moving	_	_	_	_
6-2	877-881	from	_	_	_	_
6-3	882-889	complex	abstract[39]	new[39]	_	_
6-4	890-900	biological	abstract[39]	new[39]	_	_
6-5	901-914	relationships	abstract[39]	new[39]	_	_
6-6	915-917	to	abstract[39]	new[39]	_	_
6-7	918-924	simple	abstract[39]|abstract[41]	new[39]|new[41]	coref	23-11[231_41]
6-8	925-929	QSAR	abstract[39]|organization|abstract[41]	new[39]|new|new[41]	coref	9-9
6-9	930-936	models	abstract[39]|abstract[41]	new[39]|new[41]	_	_
6-10	937-942	seems	_	_	_	_
6-11	943-945	to	_	_	_	_
6-12	946-948	be	_	_	_	_
6-13	949-950	a	event[42]	new[42]	_	_
6-14	951-952	‘	event[42]	new[42]	_	_
6-15	953-960	triumph	event[42]	new[42]	_	_
6-16	961-963	of	event[42]	new[42]	_	_
6-17	964-968	hope	event[42]|abstract	new[42]|new	_	_
6-18	969-973	over	event[42]	new[42]	_	_
6-19	974-984	experience	event[42]|abstract	new[42]|new	_	_
6-20	985-986	,	_	_	_	_
6-21	987-988	’	_	_	_	_
6-22	989-994	since	_	_	_	_
6-23	995-1003	modelers	person	new	_	_
6-24	1004-1013	sometimes	_	_	_	_
6-25	1014-1017	are	_	_	_	_
6-26	1018-1025	playing	_	_	_	_
6-27	1026-1027	a	event[48]	new[48]	_	_
6-28	1028-1029	‘	event[48]	new[48]	_	_
6-29	1030-1035	glass	object|event[48]	new|new[48]	_	_
6-30	1036-1040	bead	object|event[48]	new|new[48]	_	_
6-31	1041-1045	game	event[48]	new[48]	_	_
6-32	1046-1047	.	_	_	_	_
6-33	1048-1049	’	_	_	_	_

#Text=The quantitative mapping of experimental/calculated properties/descriptors into the ADMET-driven molecular potency is frequently a ‘ hit-or-miss affair . ’ Therefore , some structure – activity relationship ( SAR)-mediated guides are urgently needed at the ‘ pre-synthesis ’ stage .
7-1	1050-1053	The	abstract[49]	new[49]	coref	7-13[53_49]
7-2	1054-1066	quantitative	abstract[49]	new[49]	_	_
7-3	1067-1074	mapping	abstract[49]	new[49]	_	_
7-4	1075-1077	of	abstract[49]	new[49]	_	_
7-5	1078-1101	experimental/calculated	abstract[49]|abstract[50]	new[49]|new[50]	_	_
7-6	1102-1124	properties/descriptors	abstract[49]|abstract[50]	new[49]|new[50]	_	_
7-7	1125-1129	into	abstract[49]|abstract[50]	new[49]|new[50]	_	_
7-8	1130-1133	the	abstract[49]|abstract[50]|abstract[52]	new[49]|new[50]|new[52]	coref	17-37[165_52]
7-9	1134-1146	ADMET-driven	abstract[49]|abstract[50]|abstract|abstract[52]	new[49]|new[50]|new|new[52]	_	_
7-10	1147-1156	molecular	abstract[49]|abstract[50]|abstract[52]	new[49]|new[50]|new[52]	_	_
7-11	1157-1164	potency	abstract[49]|abstract[50]|abstract[52]	new[49]|new[50]|new[52]	_	_
7-12	1165-1167	is	_	_	_	_
7-13	1168-1178	frequently	abstract[53]	giv[53]	_	_
7-14	1179-1180	a	abstract[53]	giv[53]	_	_
7-15	1181-1182	‘	abstract[53]	giv[53]	_	_
7-16	1183-1194	hit-or-miss	abstract[53]	giv[53]	_	_
7-17	1195-1201	affair	abstract[53]	giv[53]	_	_
7-18	1202-1203	.	abstract[53]	giv[53]	_	_
7-19	1204-1205	’	abstract[53]|abstract[54]	giv[53]|giv[54]	coref	7-25[0_54]
7-20	1206-1215	Therefore	abstract[53]|abstract[54]	giv[53]|giv[54]	_	_
7-21	1216-1217	,	abstract[53]|abstract[54]	giv[53]|giv[54]	_	_
7-22	1218-1222	some	abstract[53]|abstract[54]	giv[53]|giv[54]	_	_
7-23	1223-1232	structure	abstract[53]|abstract[54]	giv[53]|giv[54]	_	_
7-24	1233-1234	–	abstract[53]	giv[53]	_	_
7-25	1235-1243	activity	abstract[53]|abstract|abstract[56]	giv[53]|giv|new[56]	coref|coref	8-18|8-18
7-26	1244-1256	relationship	abstract[53]|abstract[56]	giv[53]|new[56]	_	_
7-27	1257-1258	(	_	_	_	_
7-28	1259-1272	SAR)-mediated	abstract[57]	new[57]	_	_
7-29	1273-1279	guides	abstract[57]	new[57]	_	_
7-30	1280-1283	are	_	_	_	_
7-31	1284-1292	urgently	_	_	_	_
7-32	1293-1299	needed	_	_	_	_
7-33	1300-1302	at	_	_	_	_
7-34	1303-1306	the	time[59]	new[59]	_	_
7-35	1307-1308	‘	abstract[58]|time[59]	new[58]|new[59]	_	_
7-36	1309-1322	pre-synthesis	abstract[58]|time[59]	new[58]|new[59]	_	_
7-37	1323-1324	’	abstract[58]|time[59]	new[58]|new[59]	_	_
7-38	1325-1330	stage	time[59]	new[59]	_	_
7-39	1331-1332	.	_	_	_	_

#Text=Molecular similarity is unarguably at the core of many SAR-based methods , assuming that small variations in structure lead to small changes in activity .
8-1	1333-1342	Molecular	abstract[60]	new[60]	coref	9-14[71_60]
8-2	1343-1353	similarity	abstract[60]	new[60]	_	_
8-3	1354-1356	is	_	_	_	_
8-4	1357-1367	unarguably	_	_	_	_
8-5	1368-1370	at	_	_	_	_
8-6	1371-1374	the	abstract[61]	new[61]	_	_
8-7	1375-1379	core	abstract[61]	new[61]	_	_
8-8	1380-1382	of	abstract[61]	new[61]	_	_
8-9	1383-1387	many	abstract[61]|abstract[62]	new[61]|new[62]	coref	15-27[0_62]
8-10	1388-1397	SAR-based	abstract[61]|abstract[62]	new[61]|new[62]	_	_
8-11	1398-1405	methods	abstract[61]|abstract[62]	new[61]|new[62]	_	_
8-12	1406-1407	,	_	_	_	_
8-13	1408-1416	assuming	_	_	_	_
8-14	1417-1421	that	_	_	_	_
8-15	1422-1427	small	abstract[63]	new[63]	coref	21-9[209_63]
8-16	1428-1438	variations	abstract[63]	new[63]	_	_
8-17	1439-1441	in	abstract[63]	new[63]	_	_
8-18	1442-1451	structure	abstract[63]|abstract	new[63]|giv	coref	8-24
8-19	1452-1456	lead	abstract[63]	new[63]	_	_
8-20	1457-1459	to	abstract[63]	new[63]	_	_
8-21	1460-1465	small	abstract[63]|abstract[65]	new[63]|giv[65]	coref	17-19[161_65]
8-22	1466-1473	changes	abstract[63]|abstract[65]	new[63]|giv[65]	_	_
8-23	1474-1476	in	abstract[63]|abstract[65]	new[63]|giv[65]	_	_
8-24	1477-1485	activity	abstract[63]|abstract[65]|abstract	new[63]|giv[65]|giv	coref	18-34
8-25	1486-1487	.	_	_	_	_

#Text=In other words , the working tenet of QSAR is that molecules with high similarity share common effects ( similarity principle ) ; however , the validity of the assumption is still questionable — there is no absolute standard ( or metric ) of similarity .
9-1	1488-1490	In	_	_	_	_
9-2	1491-1496	other	abstract[67]	new[67]	coref	18-2[174_67]
9-3	1497-1502	words	abstract[67]	new[67]	_	_
9-4	1503-1504	,	_	_	_	_
9-5	1505-1508	the	abstract[68]	new[68]	_	_
9-6	1509-1516	working	abstract[68]	new[68]	_	_
9-7	1517-1522	tenet	abstract[68]	new[68]	_	_
9-8	1523-1525	of	abstract[68]	new[68]	_	_
9-9	1526-1530	QSAR	abstract[68]|abstract	new[68]|giv	_	_
9-10	1531-1533	is	_	_	_	_
9-11	1534-1538	that	_	_	_	_
9-12	1539-1548	molecules	substance[70]	giv[70]	coref	21-48[219_70]
9-13	1549-1553	with	substance[70]	giv[70]	_	_
9-14	1554-1558	high	substance[70]|abstract[71]	giv[70]|giv[71]	coref	9-20[0_71]
9-15	1559-1569	similarity	substance[70]|abstract[71]	giv[70]|giv[71]	_	_
9-16	1570-1575	share	_	_	_	_
9-17	1576-1582	common	abstract[72]	new[72]	appos	9-20[74_72]
9-18	1583-1590	effects	abstract[72]	new[72]	_	_
9-19	1591-1592	(	_	_	_	_
9-20	1593-1603	similarity	abstract|abstract[74]	giv|giv[74]	coref|coref	9-45|9-45
9-21	1604-1613	principle	abstract[74]	giv[74]	_	_
9-22	1614-1615	)	_	_	_	_
9-23	1616-1617	;	_	_	_	_
9-24	1618-1625	however	_	_	_	_
9-25	1626-1627	,	_	_	_	_
9-26	1628-1631	the	abstract[75]	new[75]	_	_
9-27	1632-1640	validity	abstract[75]	new[75]	_	_
9-28	1641-1643	of	abstract[75]	new[75]	_	_
9-29	1644-1647	the	abstract[75]|abstract[76]	new[75]|new[76]	_	_
9-30	1648-1658	assumption	abstract[75]|abstract[76]	new[75]|new[76]	_	_
9-31	1659-1661	is	_	_	_	_
9-32	1662-1667	still	_	_	_	_
9-33	1668-1680	questionable	_	_	_	_
9-34	1681-1682	—	_	_	_	_
9-35	1683-1688	there	_	_	_	_
9-36	1689-1691	is	_	_	_	_
9-37	1692-1694	no	abstract[77]	new[77]	_	_
9-38	1695-1703	absolute	abstract[77]	new[77]	_	_
9-39	1704-1712	standard	abstract[77]	new[77]	_	_
9-40	1713-1714	(	_	_	_	_
9-41	1715-1717	or	_	_	_	_
9-42	1718-1724	metric	abstract[78]	new[78]	_	_
9-43	1725-1726	)	abstract[78]	new[78]	_	_
9-44	1727-1729	of	abstract[78]	new[78]	_	_
9-45	1730-1740	similarity	abstract[78]|abstract	new[78]|giv	coref	10-4
9-46	1741-1742	.	_	_	_	_

#Text=In fact , similarity is a subjective concept directly related to aspects of human cognition ; this phenomena is sometimes called ‘ psychological proximity ’ .
10-1	1743-1745	In	_	_	_	_
10-2	1746-1750	fact	_	_	_	_
10-3	1751-1752	,	_	_	_	_
10-4	1753-1763	similarity	abstract	giv	coref	10-6[81_0]
10-5	1764-1766	is	_	_	_	_
10-6	1767-1768	a	abstract[81]	giv[81]	coref	11-8[88_81]
10-7	1769-1779	subjective	abstract[81]	giv[81]	_	_
10-8	1780-1787	concept	abstract[81]	giv[81]	_	_
10-9	1788-1796	directly	_	_	_	_
10-10	1797-1804	related	_	_	_	_
10-11	1805-1807	to	_	_	_	_
10-12	1808-1815	aspects	abstract[82]	new[82]	_	_
10-13	1816-1818	of	abstract[82]	new[82]	_	_
10-14	1819-1824	human	abstract[82]|abstract[83]	new[82]|new[83]	_	_
10-15	1825-1834	cognition	abstract[82]|abstract[83]	new[82]|new[83]	_	_
10-16	1835-1836	;	_	_	_	_
10-17	1837-1841	this	abstract[84]	new[84]	_	_
10-18	1842-1851	phenomena	abstract[84]	new[84]	_	_
10-19	1852-1854	is	_	_	_	_
10-20	1855-1864	sometimes	_	_	_	_
10-21	1865-1871	called	_	_	_	_
10-22	1872-1873	‘	abstract[85]	new[85]	_	_
10-23	1874-1887	psychological	abstract[85]	new[85]	_	_
10-24	1888-1897	proximity	abstract[85]	new[85]	_	_
10-25	1898-1899	’	abstract[85]	new[85]	_	_
10-26	1900-1901	.	_	_	_	_

#Text=Maggiora ’s provocative statement that , “ Similarity , like pornography , is difficult to define , but you know it when you see it , ” is probably a better illustration of cognitive aspects of similarity .
11-1	1902-1910	Maggiora	person[86]|abstract[87]	new[86]|new[87]	_	_
11-2	1911-1913	’s	person[86]|abstract[87]	new[86]|new[87]	_	_
11-3	1914-1925	provocative	abstract[87]	new[87]	_	_
11-4	1926-1935	statement	abstract[87]	new[87]	_	_
11-5	1936-1940	that	_	_	_	_
11-6	1941-1942	,	_	_	_	_
11-7	1943-1944	“	_	_	_	_
11-8	1945-1955	Similarity	abstract[88]	giv[88]	coref	11-37[0_88]
11-9	1956-1957	,	abstract[88]	giv[88]	_	_
11-10	1958-1962	like	abstract[88]	giv[88]	_	_
11-11	1963-1974	pornography	abstract[88]|abstract	giv[88]|new	ana	11-21
11-12	1975-1976	,	_	_	_	_
11-13	1977-1979	is	_	_	_	_
11-14	1980-1989	difficult	_	_	_	_
11-15	1990-1992	to	_	_	_	_
11-16	1993-1999	define	_	_	_	_
11-17	2000-2001	,	_	_	_	_
11-18	2002-2005	but	_	_	_	_
11-19	2006-2009	you	person	acc	ana	11-23
11-20	2010-2014	know	_	_	_	_
11-21	2015-2017	it	abstract	giv	ana	11-25
11-22	2018-2022	when	_	_	_	_
11-23	2023-2026	you	person	giv	_	_
11-24	2027-2030	see	_	_	_	_
11-25	2031-2033	it	abstract	giv	_	_
11-26	2034-2035	,	_	_	_	_
11-27	2036-2037	”	_	_	_	_
11-28	2038-2040	is	_	_	_	_
11-29	2041-2049	probably	object[94]	new[94]	_	_
11-30	2050-2051	a	object[94]	new[94]	_	_
11-31	2052-2058	better	object[94]	new[94]	_	_
11-32	2059-2071	illustration	object[94]	new[94]	_	_
11-33	2072-2074	of	object[94]	new[94]	_	_
11-34	2075-2084	cognitive	object[94]|abstract[95]	new[94]|new[95]	_	_
11-35	2085-2092	aspects	object[94]|abstract[95]	new[94]|new[95]	_	_
11-36	2093-2095	of	object[94]|abstract[95]	new[94]|new[95]	_	_
11-37	2096-2106	similarity	object[94]|abstract[95]|abstract	new[94]|new[95]|giv	coref	12-19
11-38	2107-2108	.	_	_	_	_

#Text=Despite the presence of fluid scientific boundaries , e. g. , some similarity metrics exhibit size-dependent behavior — similarity quantification is still a powerful concept that allows us to specify ( with some confidence ) the shared host – quest interactions .
12-1	2109-2116	Despite	_	_	_	_
12-2	2117-2120	the	abstract[97]	new[97]	_	_
12-3	2121-2129	presence	abstract[97]	new[97]	_	_
12-4	2130-2132	of	abstract[97]	new[97]	_	_
12-5	2133-2138	fluid	abstract[97]|abstract[98]	new[97]|new[98]	appos	12-9[99_98]
12-6	2139-2149	scientific	abstract[97]|abstract[98]	new[97]|new[98]	_	_
12-7	2150-2160	boundaries	abstract[97]|abstract[98]	new[97]|new[98]	_	_
12-8	2161-2162	,	_	_	_	_
12-9	2163-2165	e.	abstract[99]	giv[99]	appos	12-12[100_99]
12-10	2166-2168	g.	abstract[99]	giv[99]	_	_
12-11	2169-2170	,	_	_	_	_
12-12	2171-2175	some	abstract[100]	giv[100]	_	_
12-13	2176-2186	similarity	abstract[100]	giv[100]	_	_
12-14	2187-2194	metrics	abstract[100]|abstract	giv[100]|new	coref	25-17[250_0]
12-15	2195-2202	exhibit	abstract[100]	giv[100]	_	_
12-16	2203-2217	size-dependent	abstract[100]|abstract[102]	giv[100]|new[102]	_	_
12-17	2218-2226	behavior	abstract[100]|abstract[102]	giv[100]|new[102]	_	_
12-18	2227-2228	—	_	_	_	_
12-19	2229-2239	similarity	abstract|abstract[104]	giv|new[104]	coref|coref|coref|coref	12-22[105_104]|13-12[113_0]|12-22[105_104]|13-12[113_0]
12-20	2240-2254	quantification	abstract[104]	new[104]	_	_
12-21	2255-2257	is	_	_	_	_
12-22	2258-2263	still	abstract[105]	giv[105]	coref	25-1[243_105]
12-23	2264-2265	a	abstract[105]	giv[105]	_	_
12-24	2266-2274	powerful	abstract[105]	giv[105]	_	_
12-25	2275-2282	concept	abstract[105]	giv[105]	_	_
12-26	2283-2287	that	_	_	_	_
12-27	2288-2294	allows	_	_	_	_
12-28	2295-2297	us	person	acc	ana	19-3
12-29	2298-2300	to	_	_	_	_
12-30	2301-2308	specify	_	_	_	_
12-31	2309-2310	(	_	_	_	_
12-32	2311-2315	with	_	_	_	_
12-33	2316-2320	some	abstract[107]	new[107]	_	_
12-34	2321-2331	confidence	abstract[107]	new[107]	_	_
12-35	2332-2333	)	_	_	_	_
12-36	2334-2337	the	person[108]	new[108]	_	_
12-37	2338-2344	shared	person[108]	new[108]	_	_
12-38	2345-2349	host	person[108]	new[108]	_	_
12-39	2350-2351	–	_	_	_	_
12-40	2352-2357	quest	abstract|abstract[110]	new|new[110]	_	_
12-41	2358-2370	interactions	abstract[110]	new[110]	_	_
12-42	2371-2372	.	_	_	_	_

#Text=In fact , the idea of specifying a numerical measure of the intermolecular similarity based on the degree of the resemblance between two objects , each described by a number of attributes , has been widely applied in chemical information systems .
13-1	2373-2375	In	_	_	_	_
13-2	2376-2380	fact	_	_	_	_
13-3	2381-2382	,	_	_	_	_
13-4	2383-2386	the	abstract[111]	new[111]	coref	17-10[160_111]
13-5	2387-2391	idea	abstract[111]	new[111]	_	_
13-6	2392-2394	of	_	_	_	_
13-7	2395-2405	specifying	_	_	_	_
13-8	2406-2407	a	abstract[112]	new[112]	_	_
13-9	2408-2417	numerical	abstract[112]	new[112]	_	_
13-10	2418-2425	measure	abstract[112]	new[112]	_	_
13-11	2426-2428	of	abstract[112]	new[112]	_	_
13-12	2429-2432	the	abstract[112]|abstract[113]	new[112]|giv[113]	coref	15-51[0_113]
13-13	2433-2447	intermolecular	abstract[112]|abstract[113]	new[112]|giv[113]	_	_
13-14	2448-2458	similarity	abstract[112]|abstract[113]	new[112]|giv[113]	_	_
13-15	2459-2464	based	_	_	_	_
13-16	2465-2467	on	_	_	_	_
13-17	2468-2471	the	abstract[114]	new[114]	_	_
13-18	2472-2478	degree	abstract[114]	new[114]	_	_
13-19	2479-2481	of	abstract[114]	new[114]	_	_
13-20	2482-2485	the	abstract[114]|abstract[115]	new[114]|new[115]	ana	13-26[0_115]
13-21	2486-2497	resemblance	abstract[114]|abstract[115]	new[114]|new[115]	_	_
13-22	2498-2505	between	abstract[114]|abstract[115]	new[114]|new[115]	_	_
13-23	2506-2509	two	abstract[114]|abstract[115]|object[116]	new[114]|new[115]|new[116]	coref	14-37[0_116]
13-24	2510-2517	objects	abstract[114]|abstract[115]|object[116]	new[114]|new[115]|new[116]	_	_
13-25	2518-2519	,	_	_	_	_
13-26	2520-2524	each	abstract	giv	coref	14-33[127_0]
13-27	2525-2534	described	_	_	_	_
13-28	2535-2537	by	_	_	_	_
13-29	2538-2539	a	abstract[118]	new[118]	_	_
13-30	2540-2546	number	abstract[118]	new[118]	_	_
13-31	2547-2549	of	abstract[118]	new[118]	_	_
13-32	2550-2560	attributes	abstract[118]	new[118]	_	_
13-33	2561-2562	,	_	_	_	_
13-34	2563-2566	has	_	_	_	_
13-35	2567-2571	been	_	_	_	_
13-36	2572-2578	widely	_	_	_	_
13-37	2579-2586	applied	_	_	_	_
13-38	2587-2589	in	_	_	_	_
13-39	2590-2598	chemical	abstract[119]	new[119]	_	_
13-40	2599-2610	information	abstract[119]	new[119]	_	_
13-41	2611-2618	systems	abstract[119]	new[119]	_	_
13-42	2619-2620	.	_	_	_	_

#Text=A set of characteristics might be denoted by a bit-string representation , sometimes augmented with the weighting factors , assigning varying importance to the particular descriptors to calculate a quantitative measure of the structural resemblance between objects , for instance Tanimoto coefficient .
14-1	2621-2622	A	abstract[120]	new[120]	coref	15-17[0_120]
14-2	2623-2626	set	abstract[120]	new[120]	_	_
14-3	2627-2629	of	abstract[120]	new[120]	_	_
14-4	2630-2645	characteristics	abstract[120]	new[120]	_	_
14-5	2646-2651	might	_	_	_	_
14-6	2652-2654	be	_	_	_	_
14-7	2655-2662	denoted	_	_	_	_
14-8	2663-2665	by	_	_	_	_
14-9	2666-2667	a	abstract[121]	new[121]	_	_
14-10	2668-2678	bit-string	abstract[121]	new[121]	_	_
14-11	2679-2693	representation	abstract[121]	new[121]	_	_
14-12	2694-2695	,	_	_	_	_
14-13	2696-2705	sometimes	_	_	_	_
14-14	2706-2715	augmented	_	_	_	_
14-15	2716-2720	with	_	_	_	_
14-16	2721-2724	the	abstract[123]	new[123]	_	_
14-17	2725-2734	weighting	abstract|abstract[123]	new|new[123]	_	_
14-18	2735-2742	factors	abstract[123]	new[123]	_	_
14-19	2743-2744	,	_	_	_	_
14-20	2745-2754	assigning	_	_	_	_
14-21	2755-2762	varying	abstract[124]	new[124]	_	_
14-22	2763-2773	importance	abstract[124]	new[124]	_	_
14-23	2774-2776	to	abstract[124]	new[124]	_	_
14-24	2777-2780	the	abstract[124]|abstract[125]	new[124]|giv[125]	_	_
14-25	2781-2791	particular	abstract[124]|abstract[125]	new[124]|giv[125]	_	_
14-26	2792-2803	descriptors	abstract[124]|abstract[125]	new[124]|giv[125]	_	_
14-27	2804-2806	to	_	_	_	_
14-28	2807-2816	calculate	_	_	_	_
14-29	2817-2818	a	abstract[126]	new[126]	_	_
14-30	2819-2831	quantitative	abstract[126]	new[126]	_	_
14-31	2832-2839	measure	abstract[126]	new[126]	_	_
14-32	2840-2842	of	abstract[126]	new[126]	_	_
14-33	2843-2846	the	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-34	2847-2857	structural	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-35	2858-2869	resemblance	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-36	2870-2877	between	abstract[126]|abstract[127]	new[126]|giv[127]	_	_
14-37	2878-2885	objects	abstract[126]|abstract[127]|object	new[126]|giv[127]|giv	_	_
14-38	2886-2887	,	_	_	_	_
14-39	2888-2891	for	_	_	_	_
14-40	2892-2900	instance	_	_	_	_
14-41	2901-2909	Tanimoto	person|abstract[130]	new|new[130]	_	_
14-42	2910-2921	coefficient	abstract[130]	new[130]	_	_
14-43	2922-2923	.	_	_	_	_

#Text=Obviously , a crucial question that confronts drug ‘ hunters ’ is , which properties or features should be employed in the receptor-dependent ( RD ) methods that rely on the principle of complementarity or in the receptor-independent ( RI ) ones that are mainly based on the principle of similarity ?
15-1	2924-2933	Obviously	abstract[131]	new[131]	coref	24-11[236_131]
15-2	2934-2935	,	abstract[131]	new[131]	_	_
15-3	2936-2937	a	abstract[131]	new[131]	_	_
15-4	2938-2945	crucial	abstract[131]	new[131]	_	_
15-5	2946-2954	question	abstract[131]	new[131]	_	_
15-6	2955-2959	that	_	_	_	_
15-7	2960-2969	confronts	_	_	_	_
15-8	2970-2974	drug	substance	giv	coref	16-46
15-9	2975-2976	‘	person[133]|abstract[134]	new[133]|giv[134]	coref|coref	18-10[176_134]|18-10[176_134]
15-10	2977-2984	hunters	person[133]|abstract[134]	new[133]|giv[134]	_	_
15-11	2985-2986	’	person[133]|abstract[134]	new[133]|giv[134]	_	_
15-12	2987-2989	is	abstract[134]	giv[134]	_	_
15-13	2990-2991	,	abstract[134]	giv[134]	_	_
15-14	2992-2997	which	abstract[134]	giv[134]	_	_
15-15	2998-3008	properties	abstract[134]	giv[134]	_	_
15-16	3009-3011	or	abstract[134]	giv[134]	_	_
15-17	3012-3020	features	abstract[134]|abstract	giv[134]|giv	_	_
15-18	3021-3027	should	_	_	_	_
15-19	3028-3030	be	_	_	_	_
15-20	3031-3039	employed	_	_	_	_
15-21	3040-3042	in	_	_	_	_
15-22	3043-3046	the	abstract[136]	new[136]	_	_
15-23	3047-3065	receptor-dependent	abstract[136]	new[136]	_	_
15-24	3066-3067	(	_	_	_	_
15-25	3068-3070	RD	person	new	_	_
15-26	3071-3072	)	_	_	_	_
15-27	3073-3080	methods	abstract	giv	_	_
15-28	3081-3085	that	_	_	_	_
15-29	3086-3090	rely	_	_	_	_
15-30	3091-3093	on	_	_	_	_
15-31	3094-3097	the	abstract[139]	new[139]	_	_
15-32	3098-3107	principle	abstract[139]	new[139]	_	_
15-33	3108-3110	of	abstract[139]	new[139]	_	_
15-34	3111-3126	complementarity	abstract[139]|abstract	new[139]|new	_	_
15-35	3127-3129	or	_	_	_	_
15-36	3130-3132	in	_	_	_	_
15-37	3133-3136	the	abstract[141]	new[141]	_	_
15-38	3137-3157	receptor-independent	abstract[141]	new[141]	_	_
15-39	3158-3159	(	_	_	_	_
15-40	3160-3162	RI	organization	new	_	_
15-41	3163-3164	)	_	_	_	_
15-42	3165-3169	ones	object	new	_	_
15-43	3170-3174	that	_	_	_	_
15-44	3175-3178	are	_	_	_	_
15-45	3179-3185	mainly	_	_	_	_
15-46	3186-3191	based	_	_	_	_
15-47	3192-3194	on	_	_	_	_
15-48	3195-3198	the	abstract[144]	new[144]	_	_
15-49	3199-3208	principle	abstract[144]	new[144]	_	_
15-50	3209-3211	of	abstract[144]	new[144]	_	_
15-51	3212-3222	similarity	abstract[144]|abstract	new[144]|giv	coref	25-17
15-52	3223-3224	?	_	_	_	_

#Text=Hence , many attempts have been undertaken in order to implement some rough guidelines , sometimes called ‘ rules of thumb ’ for both the ligand and structure-based in silico protocols ; however , even meeting the rules does not guarantee the final success of drug discovery projects .
16-1	3225-3230	Hence	_	_	_	_
16-2	3231-3232	,	_	_	_	_
16-3	3233-3237	many	event[146]	new[146]	_	_
16-4	3238-3246	attempts	event[146]	new[146]	_	_
16-5	3247-3251	have	_	_	_	_
16-6	3252-3256	been	_	_	_	_
16-7	3257-3267	undertaken	_	_	_	_
16-8	3268-3270	in	_	_	_	_
16-9	3271-3276	order	_	_	_	_
16-10	3277-3279	to	_	_	_	_
16-11	3280-3289	implement	_	_	_	_
16-12	3290-3294	some	abstract[147]	new[147]	_	_
16-13	3295-3300	rough	abstract[147]	new[147]	_	_
16-14	3301-3311	guidelines	abstract[147]	new[147]	_	_
16-15	3312-3313	,	_	_	_	_
16-16	3314-3323	sometimes	_	_	_	_
16-17	3324-3330	called	_	_	_	_
16-18	3331-3332	‘	abstract[148]	new[148]	coref	16-37[153_148]
16-19	3333-3338	rules	abstract[148]	new[148]	_	_
16-20	3339-3341	of	abstract[148]	new[148]	_	_
16-21	3342-3347	thumb	abstract[148]|abstract[149]|abstract[150]	new[148]|new[149]|new[150]	_	_
16-22	3348-3349	’	abstract[148]|abstract[149]|abstract[150]	new[148]|new[149]|new[150]	_	_
16-23	3350-3353	for	abstract[148]|abstract[150]	new[148]|new[150]	_	_
16-24	3354-3358	both	abstract[148]|abstract[150]	new[148]|new[150]	_	_
16-25	3359-3362	the	abstract[148]|abstract[150]	new[148]|new[150]	_	_
16-26	3363-3369	ligand	abstract[148]|abstract[150]	new[148]|new[150]	_	_
16-27	3370-3373	and	abstract[148]	new[148]	_	_
16-28	3374-3389	structure-based	abstract[148]	new[148]	_	_
16-29	3390-3392	in	_	_	_	_
16-30	3393-3399	silico	abstract|abstract[152]	giv|new[152]	_	_
16-31	3400-3409	protocols	abstract[152]	new[152]	_	_
16-32	3410-3411	;	_	_	_	_
16-33	3412-3419	however	_	_	_	_
16-34	3420-3421	,	_	_	_	_
16-35	3422-3426	even	_	_	_	_
16-36	3427-3434	meeting	_	_	_	_
16-37	3435-3438	the	abstract[153]	giv[153]	_	_
16-38	3439-3444	rules	abstract[153]	giv[153]	_	_
16-39	3445-3449	does	_	_	_	_
16-40	3450-3453	not	_	_	_	_
16-41	3454-3463	guarantee	_	_	_	_
16-42	3464-3467	the	event[154]	new[154]	_	_
16-43	3468-3473	final	event[154]	new[154]	_	_
16-44	3474-3481	success	event[154]	new[154]	_	_
16-45	3482-3484	of	event[154]	new[154]	_	_
16-46	3485-3489	drug	event[154]|substance|abstract[157]	new[154]|giv|giv[157]	coref|coref	18-14|18-14
16-47	3490-3499	discovery	event[154]|abstract|abstract[157]	new[154]|giv|giv[157]	_	_
16-48	3500-3508	projects	event[154]|abstract[157]	new[154]|giv[157]	_	_
16-49	3509-3510	.	_	_	_	_

#Text=A confusing aspect of many SAR analyses is that the ‘ fragile event ’ can occur , when even small structural changes ( colloquially termed ‘ magic methyl ’ ) can result in a boost of potency for the target , or in a more detrimental manner , can completely destroy biological response — a phenomenon known as activity ‘ hotspot ’ or activity ‘ cliff ’ in structure-activity landscape .
17-1	3511-3512	A	abstract[158]	new[158]	_	_
17-2	3513-3522	confusing	abstract[158]	new[158]	_	_
17-3	3523-3529	aspect	abstract[158]	new[158]	_	_
17-4	3530-3532	of	abstract[158]	new[158]	_	_
17-5	3533-3537	many	abstract[158]|abstract[159]	new[158]|new[159]	_	_
17-6	3538-3541	SAR	abstract[158]|abstract[159]	new[158]|new[159]	_	_
17-7	3542-3550	analyses	abstract[158]|abstract[159]	new[158]|new[159]	_	_
17-8	3551-3553	is	_	_	_	_
17-9	3554-3558	that	_	_	_	_
17-10	3559-3562	the	abstract[160]	giv[160]	_	_
17-11	3563-3564	‘	abstract[160]	giv[160]	_	_
17-12	3565-3572	fragile	abstract[160]	giv[160]	_	_
17-13	3573-3578	event	abstract[160]	giv[160]	_	_
17-14	3579-3580	’	abstract[160]	giv[160]	_	_
17-15	3581-3584	can	_	_	_	_
17-16	3585-3590	occur	_	_	_	_
17-17	3591-3592	,	_	_	_	_
17-18	3593-3597	when	_	_	_	_
17-19	3598-3602	even	abstract[161]	giv[161]	coref	21-15[210_161]
17-20	3603-3608	small	abstract[161]	giv[161]	_	_
17-21	3609-3619	structural	abstract[161]	giv[161]	_	_
17-22	3620-3627	changes	abstract[161]	giv[161]	_	_
17-23	3628-3629	(	_	_	_	_
17-24	3630-3642	colloquially	_	_	_	_
17-25	3643-3649	termed	_	_	_	_
17-26	3650-3651	‘	_	_	_	_
17-27	3652-3657	magic	abstract|abstract[163]	new|new[163]	_	_
17-28	3658-3664	methyl	abstract[163]	new[163]	_	_
17-29	3665-3666	’	_	_	_	_
17-30	3667-3668	)	_	_	_	_
17-31	3669-3672	can	_	_	_	_
17-32	3673-3679	result	_	_	_	_
17-33	3680-3682	in	_	_	_	_
17-34	3683-3684	a	event[164]	new[164]	_	_
17-35	3685-3690	boost	event[164]	new[164]	_	_
17-36	3691-3693	of	event[164]	new[164]	_	_
17-37	3694-3701	potency	event[164]|abstract[165]	new[164]|giv[165]	coref	18-13[178_165]
17-38	3702-3705	for	event[164]|abstract[165]	new[164]|giv[165]	_	_
17-39	3706-3709	the	event[164]|abstract[165]|abstract[166]	new[164]|giv[165]|new[166]	_	_
17-40	3710-3716	target	event[164]|abstract[165]|abstract[166]	new[164]|giv[165]|new[166]	_	_
17-41	3717-3718	,	_	_	_	_
17-42	3719-3721	or	_	_	_	_
17-43	3722-3724	in	_	_	_	_
17-44	3725-3726	a	abstract[167]	new[167]	_	_
17-45	3727-3731	more	abstract[167]	new[167]	_	_
17-46	3732-3743	detrimental	abstract[167]	new[167]	_	_
17-47	3744-3750	manner	abstract[167]	new[167]	_	_
17-48	3751-3752	,	_	_	_	_
17-49	3753-3756	can	_	_	_	_
17-50	3757-3767	completely	_	_	_	_
17-51	3768-3775	destroy	_	_	_	_
17-52	3776-3786	biological	abstract[168]	new[168]	coref	18-43[0_168]
17-53	3787-3795	response	abstract[168]	new[168]	_	_
17-54	3796-3797	—	_	_	_	_
17-55	3798-3799	a	abstract[169]	new[169]	_	_
17-56	3800-3810	phenomenon	abstract[169]	new[169]	_	_
17-57	3811-3816	known	_	_	_	_
17-58	3817-3819	as	_	_	_	_
17-59	3820-3828	activity	_	_	_	_
17-60	3829-3830	‘	abstract[170]	new[170]	_	_
17-61	3831-3838	hotspot	abstract[170]	new[170]	_	_
17-62	3839-3840	’	abstract[170]	new[170]	_	_
17-63	3841-3843	or	_	_	_	_
17-64	3844-3852	activity	_	_	_	_
17-65	3853-3854	‘	object[171]|abstract[173]	new[171]|new[173]	coref|coref	22-30[227_173]|22-30[227_173]
17-66	3855-3860	cliff	object[171]|abstract[173]	new[171]|new[173]	_	_
17-67	3861-3862	’	object[171]|abstract[173]	new[171]|new[173]	_	_
17-68	3863-3865	in	abstract[173]	new[173]	_	_
17-69	3866-3884	structure-activity	abstract|abstract[173]	new|new[173]	_	_
17-70	3885-3894	landscape	abstract[173]	new[173]	_	_
17-71	3895-3896	.	_	_	_	_

#Text=In other words , finding the optimal balance between ADMET-related properties and desired drug potency ( ‘ sweet spot ’ ) can be rationalized graphically by extension of the 2D similarity-based projection with activity data in the form of a ‘ biological response surface ’ or SAR landscapes .
18-1	3897-3899	In	_	_	_	_
18-2	3900-3905	other	abstract[174]	giv[174]	_	_
18-3	3906-3911	words	abstract[174]	giv[174]	_	_
18-4	3912-3913	,	_	_	_	_
18-5	3914-3921	finding	_	_	_	_
18-6	3922-3925	the	abstract[175]	new[175]	_	_
18-7	3926-3933	optimal	abstract[175]	new[175]	_	_
18-8	3934-3941	balance	abstract[175]	new[175]	_	_
18-9	3942-3949	between	abstract[175]	new[175]	_	_
18-10	3950-3963	ADMET-related	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
18-11	3964-3974	properties	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
18-12	3975-3978	and	abstract[175]|abstract[176]	new[175]|giv[176]	_	_
18-13	3979-3986	desired	abstract[175]|abstract[176]|abstract[178]	new[175]|giv[176]|giv[178]	_	_
18-14	3987-3991	drug	abstract[175]|abstract[176]|substance|abstract[178]	new[175]|giv[176]|giv|giv[178]	_	_
18-15	3992-3999	potency	abstract[175]|abstract[176]|abstract[178]	new[175]|giv[176]|giv[178]	_	_
18-16	4000-4001	(	_	_	_	_
18-17	4002-4003	‘	_	_	_	_
18-18	4004-4009	sweet	place[179]	new[179]	_	_
18-19	4010-4014	spot	place[179]	new[179]	_	_
18-20	4015-4016	’	_	_	_	_
18-21	4017-4018	)	_	_	_	_
18-22	4019-4022	can	_	_	_	_
18-23	4023-4025	be	_	_	_	_
18-24	4026-4038	rationalized	_	_	_	_
18-25	4039-4050	graphically	_	_	_	_
18-26	4051-4053	by	_	_	_	_
18-27	4054-4063	extension	abstract[180]	new[180]	_	_
18-28	4064-4066	of	abstract[180]	new[180]	_	_
18-29	4067-4070	the	abstract[180]|object[181]	new[180]|new[181]	_	_
18-30	4071-4073	2D	abstract[180]|object[181]	new[180]|new[181]	_	_
18-31	4074-4090	similarity-based	abstract[180]|object[181]	new[180]|new[181]	_	_
18-32	4091-4101	projection	abstract[180]|object[181]	new[180]|new[181]	_	_
18-33	4102-4106	with	abstract[180]|object[181]	new[180]|new[181]	_	_
18-34	4107-4115	activity	abstract[180]|object[181]|abstract|abstract[183]	new[180]|new[181]|giv|new[183]	coref|coref	19-6[190_0]|19-6[190_0]
18-35	4116-4120	data	abstract[180]|object[181]|abstract[183]	new[180]|new[181]|new[183]	_	_
18-36	4121-4123	in	abstract[180]	new[180]	_	_
18-37	4124-4127	the	abstract[180]|abstract[184]	new[180]|new[184]	_	_
18-38	4128-4132	form	abstract[180]|abstract[184]	new[180]|new[184]	_	_
18-39	4133-4135	of	abstract[180]|abstract[184]	new[180]|new[184]	_	_
18-40	4136-4137	a	abstract[180]|abstract[184]|abstract[188]	new[180]|new[184]|new[188]	coref	19-9[193_188]
18-41	4138-4139	‘	abstract[180]|abstract[184]|place[186]|abstract[188]	new[180]|new[184]|new[186]|new[188]	_	_
18-42	4140-4150	biological	abstract[180]|abstract[184]|place[186]|abstract[188]	new[180]|new[184]|new[186]|new[188]	_	_
18-43	4151-4159	response	abstract[180]|abstract[184]|abstract|place[186]|abstract[188]	new[180]|new[184]|giv|new[186]|new[188]	coref	22-23
18-44	4160-4167	surface	abstract[180]|abstract[184]|place[186]|abstract[188]	new[180]|new[184]|new[186]|new[188]	_	_
18-45	4168-4169	’	abstract[180]|abstract[184]|place[186]|abstract[188]	new[180]|new[184]|new[186]|new[188]	_	_
18-46	4170-4172	or	abstract[180]|abstract[184]|abstract[188]	new[180]|new[184]|new[188]	_	_
18-47	4173-4176	SAR	abstract[180]|abstract[184]|place|abstract[188]	new[180]|new[184]|new|new[188]	coref	21-23
18-48	4177-4187	landscapes	abstract[180]|abstract[184]|abstract[188]	new[180]|new[184]|new[188]	_	_
18-49	4188-4189	.	_	_	_	_

#Text=Intuitively , we feel that the structure – activity landscapes are heterogeneous in nature with unevenly distributed regions that are reminiscent of Tolkien ’s Misty Mountains with gently slopes , steep cliffs and stony bridges .
19-1	4190-4201	Intuitively	_	_	_	_
19-2	4202-4203	,	_	_	_	_
19-3	4204-4206	we	person	giv	_	_
19-4	4207-4211	feel	_	_	_	_
19-5	4212-4216	that	_	_	_	_
19-6	4217-4220	the	abstract[190]|abstract[191]	giv[190]|new[191]	coref|coref|coref|coref	19-9[0_190]|25-23[252_191]|19-9[0_190]|25-23[252_191]
19-7	4221-4230	structure	abstract[190]|abstract[191]	giv[190]|new[191]	_	_
19-8	4231-4232	–	abstract[191]	new[191]	_	_
19-9	4233-4241	activity	abstract[191]|abstract|abstract[193]	new[191]|giv|giv[193]	coref|coref|coref|coref	21-18|21-20[213_193]|21-18|21-20[213_193]
19-10	4242-4252	landscapes	abstract[191]|abstract[193]	new[191]|giv[193]	_	_
19-11	4253-4256	are	_	_	_	_
19-12	4257-4270	heterogeneous	_	_	_	_
19-13	4271-4273	in	_	_	_	_
19-14	4274-4280	nature	abstract[194]	new[194]	_	_
19-15	4281-4285	with	abstract[194]	new[194]	_	_
19-16	4286-4294	unevenly	abstract[194]|place[195]	new[194]|new[195]	coref	20-14[205_195]
19-17	4295-4306	distributed	abstract[194]|place[195]	new[194]|new[195]	_	_
19-18	4307-4314	regions	abstract[194]|place[195]	new[194]|new[195]	_	_
19-19	4315-4319	that	_	_	_	_
19-20	4320-4323	are	_	_	_	_
19-21	4324-4335	reminiscent	_	_	_	_
19-22	4336-4338	of	_	_	_	_
19-23	4339-4346	Tolkien	person[196]|object[198]	new[196]|new[198]	_	_
19-24	4347-4349	’s	person[196]|object[198]	new[196]|new[198]	_	_
19-25	4350-4355	Misty	person|object[198]	new|new[198]	_	_
19-26	4356-4365	Mountains	object[198]	new[198]	_	_
19-27	4366-4370	with	object[198]	new[198]	_	_
19-28	4371-4377	gently	object[198]|abstract[199]	new[198]|new[199]	_	_
19-29	4378-4384	slopes	object[198]|abstract[199]	new[198]|new[199]	_	_
19-30	4385-4386	,	object[198]	new[198]	_	_
19-31	4387-4392	steep	object[198]|object[200]	new[198]|new[200]	coref	22-27[225_200]
19-32	4393-4399	cliffs	object[198]|object[200]	new[198]|new[200]	_	_
19-33	4400-4403	and	object[198]	new[198]	_	_
19-34	4404-4409	stony	object[198]|object[201]	new[198]|new[201]	coref	23-3[228_201]
19-35	4410-4417	bridges	object[198]|object[201]	new[198]|new[201]	_	_
19-36	4418-4419	.	_	_	_	_

#Text=Geographically , a successful voyage ( or exploration ) requires a map indicating smooth and flat regions that are easy to navigate or jagged parts that are tough to traverse .
20-1	4420-4434	Geographically	_	_	_	_
20-2	4435-4436	,	_	_	_	_
20-3	4437-4438	a	event[202]	new[202]	_	_
20-4	4439-4449	successful	event[202]	new[202]	_	_
20-5	4450-4456	voyage	event[202]	new[202]	_	_
20-6	4457-4458	(	_	_	_	_
20-7	4459-4461	or	_	_	_	_
20-8	4462-4473	exploration	event	new	_	_
20-9	4474-4475	)	_	_	_	_
20-10	4476-4484	requires	_	_	_	_
20-11	4485-4486	a	object[204]	new[204]	_	_
20-12	4487-4490	map	object[204]	new[204]	_	_
20-13	4491-4501	indicating	_	_	_	_
20-14	4502-4508	smooth	place[205]	giv[205]	coref	22-11[221_205]
20-15	4509-4512	and	place[205]	giv[205]	_	_
20-16	4513-4517	flat	place[205]	giv[205]	_	_
20-17	4518-4525	regions	place[205]	giv[205]	_	_
20-18	4526-4530	that	_	_	_	_
20-19	4531-4534	are	_	_	_	_
20-20	4535-4539	easy	_	_	_	_
20-21	4540-4542	to	_	_	_	_
20-22	4543-4551	navigate	_	_	_	_
20-23	4552-4554	or	_	_	_	_
20-24	4555-4561	jagged	abstract[206]	new[206]	_	_
20-25	4562-4567	parts	abstract[206]	new[206]	_	_
20-26	4568-4572	that	_	_	_	_
20-27	4573-4576	are	_	_	_	_
20-28	4577-4582	tough	_	_	_	_
20-29	4583-4585	to	_	_	_	_
20-30	4586-4594	traverse	_	_	_	_
20-31	4595-4596	.	_	_	_	_

#Text=Chemically , gently sloped hills pinpoint areas where gradual structural variations are accompanied by moderate changes in activity , whereas in flat SAR landscapes , the biological data varies little over the wide modifications in the compound structure — further substitutions are not likely to result in more potent molecules .
21-1	4597-4607	Chemically	_	_	_	_
21-2	4608-4609	,	_	_	_	_
21-3	4610-4616	gently	object[207]	new[207]	_	_
21-4	4617-4623	sloped	object[207]	new[207]	_	_
21-5	4624-4629	hills	object[207]	new[207]	_	_
21-6	4630-4638	pinpoint	_	_	_	_
21-7	4639-4644	areas	place	new	_	_
21-8	4645-4650	where	_	_	_	_
21-9	4651-4658	gradual	abstract[209]	giv[209]	coref	22-22[224_209]
21-10	4659-4669	structural	abstract[209]	giv[209]	_	_
21-11	4670-4680	variations	abstract[209]	giv[209]	_	_
21-12	4681-4684	are	_	_	_	_
21-13	4685-4696	accompanied	_	_	_	_
21-14	4697-4699	by	_	_	_	_
21-15	4700-4708	moderate	abstract[210]	giv[210]	_	_
21-16	4709-4716	changes	abstract[210]	giv[210]	_	_
21-17	4717-4719	in	abstract[210]	giv[210]	_	_
21-18	4720-4728	activity	abstract[210]|abstract	giv[210]|giv	coref	21-36[217_0]
21-19	4729-4730	,	_	_	_	_
21-20	4731-4738	whereas	abstract[213]	giv[213]	_	_
21-21	4739-4741	in	abstract[213]	giv[213]	_	_
21-22	4742-4746	flat	abstract[213]	giv[213]	_	_
21-23	4747-4750	SAR	substance|abstract[213]	giv|giv[213]	coref	23-13
21-24	4751-4761	landscapes	abstract[213]	giv[213]	_	_
21-25	4762-4763	,	_	_	_	_
21-26	4764-4767	the	abstract[214]	new[214]	_	_
21-27	4768-4778	biological	abstract[214]	new[214]	_	_
21-28	4779-4783	data	abstract[214]	new[214]	_	_
21-29	4784-4790	varies	_	_	_	_
21-30	4791-4797	little	_	_	_	_
21-31	4798-4802	over	_	_	_	_
21-32	4803-4806	the	abstract[215]	giv[215]	coref	22-5[220_215]
21-33	4807-4811	wide	abstract[215]	giv[215]	_	_
21-34	4812-4825	modifications	abstract[215]	giv[215]	_	_
21-35	4826-4828	in	abstract[215]	giv[215]	_	_
21-36	4829-4832	the	abstract[215]|abstract[217]	giv[215]|giv[217]	coref	22-31[0_217]
21-37	4833-4841	compound	abstract[215]|place|abstract[217]	giv[215]|new|giv[217]	_	_
21-38	4842-4851	structure	abstract[215]|abstract[217]	giv[215]|giv[217]	_	_
21-39	4852-4853	—	_	_	_	_
21-40	4854-4861	further	event[218]	new[218]	_	_
21-41	4862-4875	substitutions	event[218]	new[218]	_	_
21-42	4876-4879	are	_	_	_	_
21-43	4880-4883	not	_	_	_	_
21-44	4884-4890	likely	_	_	_	_
21-45	4891-4893	to	_	_	_	_
21-46	4894-4900	result	_	_	_	_
21-47	4901-4903	in	_	_	_	_
21-48	4904-4908	more	substance[219]	giv[219]	coref	23-9[0_219]
21-49	4909-4915	potent	substance[219]	giv[219]	_	_
21-50	4916-4925	molecules	substance[219]	giv[219]	_	_
21-51	4926-4927	.	_	_	_	_

#Text=In fact , disallowed structural modifications can be highlighted in the sharply non-uniform regions where chemically related compounds are characterized by huge response variations , forming steep cliffs in the activity landscape .
22-1	4928-4930	In	_	_	_	_
22-2	4931-4935	fact	_	_	_	_
22-3	4936-4937	,	_	_	_	_
22-4	4938-4948	disallowed	_	_	_	_
22-5	4949-4959	structural	abstract[220]	giv[220]	_	_
22-6	4960-4973	modifications	abstract[220]	giv[220]	_	_
22-7	4974-4977	can	_	_	_	_
22-8	4978-4980	be	_	_	_	_
22-9	4981-4992	highlighted	_	_	_	_
22-10	4993-4995	in	_	_	_	_
22-11	4996-4999	the	place[221]	giv[221]	_	_
22-12	5000-5007	sharply	place[221]	giv[221]	_	_
22-13	5008-5019	non-uniform	place[221]	giv[221]	_	_
22-14	5020-5027	regions	place[221]	giv[221]	_	_
22-15	5028-5033	where	_	_	_	_
22-16	5034-5044	chemically	substance[222]	new[222]	_	_
22-17	5045-5052	related	substance[222]	new[222]	_	_
22-18	5053-5062	compounds	substance[222]	new[222]	_	_
22-19	5063-5066	are	_	_	_	_
22-20	5067-5080	characterized	_	_	_	_
22-21	5081-5083	by	_	_	_	_
22-22	5084-5088	huge	abstract[224]	giv[224]	_	_
22-23	5089-5097	response	abstract|abstract[224]	giv|giv[224]	_	_
22-24	5098-5108	variations	abstract[224]	giv[224]	_	_
22-25	5109-5110	,	_	_	_	_
22-26	5111-5118	forming	_	_	_	_
22-27	5119-5124	steep	object[225]	giv[225]	coref	25-5[245_225]
22-28	5125-5131	cliffs	object[225]	giv[225]	_	_
22-29	5132-5134	in	object[225]	giv[225]	_	_
22-30	5135-5138	the	object[225]|abstract[227]	giv[225]|giv[227]	coref	25-27[0_227]
22-31	5139-5147	activity	object[225]|abstract|abstract[227]	giv[225]|giv|giv[227]	coref	24-5
22-32	5148-5157	landscape	object[225]|abstract[227]	giv[225]|giv[227]	_	_
22-33	5158-5159	.	_	_	_	_

#Text=Moreover , chemical bridges can be observed with molecules connecting different local SAR models .
23-1	5160-5168	Moreover	_	_	_	_
23-2	5169-5170	,	_	_	_	_
23-3	5171-5179	chemical	object[228]	giv[228]	_	_
23-4	5180-5187	bridges	object[228]	giv[228]	_	_
23-5	5188-5191	can	_	_	_	_
23-6	5192-5194	be	_	_	_	_
23-7	5195-5203	observed	_	_	_	_
23-8	5204-5208	with	_	_	_	_
23-9	5209-5218	molecules	substance	giv	_	_
23-10	5219-5229	connecting	_	_	_	_
23-11	5230-5239	different	abstract[231]	giv[231]	_	_
23-12	5240-5245	local	abstract[231]	giv[231]	_	_
23-13	5246-5249	SAR	place|abstract[231]	giv|giv[231]	coref	25-37
23-14	5250-5256	models	abstract[231]	giv[231]	_	_
23-15	5257-5258	.	_	_	_	_

#Text=The detection of the activity hotspots provides reasonable hints to the key question of medicinal chemistry regarding the impact of molecule rearrangement on the activity profile .
24-1	5259-5262	The	abstract[232]	new[232]	_	_
24-2	5263-5272	detection	abstract[232]	new[232]	_	_
24-3	5273-5275	of	abstract[232]	new[232]	_	_
24-4	5276-5279	the	abstract[232]|abstract[234]	new[232]|new[234]	_	_
24-5	5280-5288	activity	abstract[232]|abstract|abstract[234]	new[232]|giv|new[234]	coref	24-25
24-6	5289-5297	hotspots	abstract[232]|abstract[234]	new[232]|new[234]	_	_
24-7	5298-5306	provides	_	_	_	_
24-8	5307-5317	reasonable	abstract[235]	new[235]	_	_
24-9	5318-5323	hints	abstract[235]	new[235]	_	_
24-10	5324-5326	to	abstract[235]	new[235]	_	_
24-11	5327-5330	the	abstract[235]|abstract[236]	new[235]|giv[236]	_	_
24-12	5331-5334	key	abstract[235]|abstract[236]	new[235]|giv[236]	_	_
24-13	5335-5343	question	abstract[235]|abstract[236]	new[235]|giv[236]	_	_
24-14	5344-5346	of	abstract[235]|abstract[236]	new[235]|giv[236]	_	_
24-15	5347-5356	medicinal	abstract[235]|abstract[236]|abstract[237]	new[235]|giv[236]|new[237]	_	_
24-16	5357-5366	chemistry	abstract[235]|abstract[236]|abstract[237]	new[235]|giv[236]|new[237]	_	_
24-17	5367-5376	regarding	_	_	_	_
24-18	5377-5380	the	abstract[238]	new[238]	_	_
24-19	5381-5387	impact	abstract[238]	new[238]	_	_
24-20	5388-5390	of	abstract[238]	new[238]	_	_
24-21	5391-5399	molecule	abstract[238]|abstract|abstract[240]	new[238]|new|new[240]	_	_
24-22	5400-5413	rearrangement	abstract[238]|abstract[240]	new[238]|new[240]	_	_
24-23	5414-5416	on	abstract[238]|abstract[240]	new[238]|new[240]	_	_
24-24	5417-5420	the	abstract[238]|abstract[240]|abstract[242]	new[238]|new[240]|new[242]	_	_
24-25	5421-5429	activity	abstract[238]|abstract[240]|abstract|abstract[242]	new[238]|new[240]|giv|new[242]	coref	25-5
24-26	5430-5437	profile	abstract[238]|abstract[240]|abstract[242]	new[238]|new[240]|new[242]	_	_
24-27	5438-5439	.	_	_	_	_

#Text=The numerical quantification of activity cliffs is frequently performed using a variety of fingerprint representations or similarity metrics ; for instance , the structure – activity landscape index ( SALI ) has been proposed to evaluate SAR smoothness .
25-1	5440-5443	The	abstract[243]	giv[243]	_	_
25-2	5444-5453	numerical	abstract[243]	giv[243]	_	_
25-3	5454-5468	quantification	abstract[243]	giv[243]	_	_
25-4	5469-5471	of	abstract[243]	giv[243]	_	_
25-5	5472-5480	activity	abstract[243]|abstract|object[245]	giv[243]|giv|giv[245]	coref|coref	25-23[251_0]|25-23[251_0]
25-6	5481-5487	cliffs	abstract[243]|object[245]	giv[243]|giv[245]	_	_
25-7	5488-5490	is	_	_	_	_
25-8	5491-5501	frequently	_	_	_	_
25-9	5502-5511	performed	_	_	_	_
25-10	5512-5517	using	_	_	_	_
25-11	5518-5519	a	abstract[246]	new[246]	_	_
25-12	5520-5527	variety	abstract[246]	new[246]	_	_
25-13	5528-5530	of	abstract[246]	new[246]	_	_
25-14	5531-5542	fingerprint	abstract[246]|object|abstract[248]	new[246]|new|new[248]	_	_
25-15	5543-5558	representations	abstract[246]|abstract[248]	new[246]|new[248]	_	_
25-16	5559-5561	or	abstract[246]	new[246]	_	_
25-17	5562-5572	similarity	abstract[246]|abstract|abstract[250]	new[246]|giv|giv[250]	_	_
25-18	5573-5580	metrics	abstract[246]|abstract[250]	new[246]|giv[250]	_	_
25-19	5581-5582	;	_	_	_	_
25-20	5583-5586	for	_	_	_	_
25-21	5587-5595	instance	_	_	_	_
25-22	5596-5597	,	_	_	_	_
25-23	5598-5601	the	abstract[251]|abstract[252]	giv[251]|giv[252]	coref|coref	25-26[0_251]|25-26[0_251]
25-24	5602-5611	structure	abstract[251]|abstract[252]	giv[251]|giv[252]	_	_
25-25	5612-5613	–	abstract[252]	giv[252]	_	_
25-26	5614-5622	activity	abstract[252]|abstract|abstract[255]	giv[252]|giv|new[255]	_	_
25-27	5623-5632	landscape	abstract[252]|abstract|abstract[255]	giv[252]|giv|new[255]	_	_
25-28	5633-5638	index	abstract[252]|abstract[255]	giv[252]|new[255]	_	_
25-29	5639-5640	(	_	_	_	_
25-30	5641-5645	SALI	object	new	_	_
25-31	5646-5647	)	_	_	_	_
25-32	5648-5651	has	_	_	_	_
25-33	5652-5656	been	_	_	_	_
25-34	5657-5665	proposed	_	_	_	_
25-35	5666-5668	to	_	_	_	_
25-36	5669-5677	evaluate	_	_	_	_
25-37	5678-5681	SAR	abstract|abstract[258]	giv|new[258]	_	_
25-38	5682-5692	smoothness	abstract[258]	new[258]	_	_
25-39	5693-5694	.	_	_	_	_
